TPBG and breast carcinoma: The results indicated that miR-653-5p had binding sites with TPBG, and miR-653-5p inhibited while circTBPL1 promoted the expression of TPBG in breast cancer cells, inferring that miR-653-5p might be a bridge for the regulation of TPBG by circTBPL1.